EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ADVANCED‐STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL. (June 2017) - Borchmann, P.; Goergen, H.; Kobe, C.; Eichenauer, D.; Greil, R.; Lohri, A.; Novak, U.; Markova, J.; Beck, H.; Meissner, J.; Zijlstra, J.M.; Ostermann, H.; et al.